Two Doses of Nasal Spray Found to Slow Brain Ageing and Restore Memory
Researchers at Texas A&M University have developed a nasal spray that, with just two doses, dramatically reduces brain inflammation and restores memory function in aging mice. The treatment targets “neuroinflammaging” – chronic inflammation in the brain linked to age-related cognitive decline – using extracellular vesicles derived from human stem cells. Findings published in the Journal of Extracellular Vesicles suggest the approach could one day offer a simple, non-invasive therapy for conditions like Alzheimer’s disease.
How the Nasal Spray Works
The spray delivers extracellular vesicles (EVs) – tiny biological particles released by cells – directly into the brain via the nasal cavity. These EVs are sourced from human stem cells and carry proteins and genetic material that help suppress inflammatory pathways and reactivate cellular repair mechanisms. In the study, the EVs specifically targeted microglia, the brain’s immune cells, in the hippocampus – a region critical for learning and memory where age-related inflammation accumulates.
According to the research, the treatment reduced markers of neuroinflammation and restored cognitive performance in aged mice to levels comparable to younger animals. Effects lasted for months after just two intranasal doses administered weeks apart.
Targeting Neuroinflammaging
Scientists describe the underlying process as “neuroinflammaging” – a persistent, low-grade inflammation in the aging brain that contributes to cognitive decline and is thought to play a role in neurodegenerative diseases like Alzheimer’s. The nasal spray aims to interrupt this cycle by delivering anti-inflammatory signals directly to affected brain regions.
As explained by lead researcher Ashok Shetty, the approach is analogous to cooling overheated parts in an engine: “We’re targeting those hotspots of chronic inflammation and giving the brain the tools to reset and repair itself.”
Study Details and Results
The experiments used mice aged 18 months, which approximates late adulthood in humans (roughly 50s to 60s years old). Treated mice showed significant reductions in brain inflammation and improved performance in memory and learning tasks compared to control groups. Notably, the treatment worked equally well in both male and female mice.
Researchers emphasized that the therapy is designed to harness the body’s natural repair systems rather than introduce foreign substances. “We’re not just slowing decline – we’re activating the brain’s own ability to heal,” said Shetty.
Potential Implications for Human Health
While the study was conducted in mice, the researchers believe the findings have strong translational potential for humans. The non-invasive nasal delivery method avoids the risks associated with surgical or systemic treatments. A U.S. Patent has already been filed for the technology.
Shetty noted that future applications could extend beyond age-related cognitive decline to include recovery from stroke or other brain injuries where inflammation impairs healing. “Our goal is successful brain ageing – not just living longer, but living with clarity, connection, and cognitive vitality,” he said.
Frequently Asked Questions
What is neuroinflammaging?
Neuroinflammaging refers to chronic, low-grade inflammation in the brain that develops with age and is associated with memory loss, reduced cognitive function, and increased risk of neurodegenerative disorders.
How is the nasal spray administered?
The treatment involves two intranasal doses, spaced several weeks apart, delivering extracellular vesicles directly to the brain through the nasal passageway.
Has this been tested in humans?
As of now, the treatment has only been tested in animal models. Human clinical trials would be required before the therapy could be considered for clinical use.
What are extracellular vesicles?
Extracellular vesicles are minor particles released by cells that carry proteins, RNA, and other molecules. They play a role in cell-to-cell communication and can influence inflammation, immunity, and tissue repair.
Key Takeaways
- A nasal spray containing extracellular vesicles from human stem cells reduced brain inflammation and restored memory in aging mice after just two doses.
- The treatment targets neuroinflammaging – age-related inflammation in the brain linked to cognitive decline.
- Effects lasted for months in animal models, with restored performance in memory and learning tasks.
- The approach is non-invasive and leverages the brain’s natural repair mechanisms.
- Researchers believe the findings could lead to new therapies for Alzheimer’s disease, age-related cognitive decline, and brain injury recovery.
Looking Ahead
While further research is needed to confirm safety and efficacy in humans, the study represents a promising step toward accessible, low-risk interventions for brain health. As the global population ages, therapies that target the root causes of cognitive decline – rather than just symptoms – could play a vital role in promoting long-term neurological wellness.
For now, the focus remains on rigorous scientific validation. But the vision is clear: a future where a simple nasal spray could help preserve not just lifespan, but mindspan.